speb/financial-data huggingface dataset:
Financial scorecard for FCG.AX (Healthcare — Medical Care Facilities, Australia)
Report date: 2025-12-31 (quarterly)
Stock price: 0.02777777777777778
Market cap: 4007783 (USD: 2689787.248322148)
P/E ratio: 2.6845637583892614
P/B ratio: 4.075953076199435
Debt to equity: 0.1882
Current ratio: 1.19
Return on net tangible assets (%): -7.714016933207903
Buffett classification: The Gruesome
Rule of 40 score: -44.31137724550898
Altman Z-score: 3.7253043206882483 (Safe Zone)
Piotroski F-score: 1 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -0.1304651017765846
Total shareholder yield (%): -0.1304651017765846 (Minimal or Negative)
Momentum (%): 1m 0.6944444444444402, 3m -2.77777777777778, 6m 1.3888888888888886, 12m 4.861111111111119, composite 0.9163473818646265 (Flat)
Lynch category: Turnaround (confidence: Medium)
Screener: long score 4, short score 9, recommendation: Short
Revenue deceleration: no
Accrual ratio: -0.0056467462009023766
FCF conversion rate: 0.9024390243902438
Beneish M-score: -2.484324569814676 (Likely Safe)
ROE (%): -7.529617937607281
Net margin (%): -49.10179640718563
Asset turnover: 0.11787582694383701
Equity multiplier (leverage): 1.3009206467333247
ROE archetype: Low Return
Treasury beta 1y: 0.001779739187879281 (R-squared: 0.005851915433772501)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): -1132.8165137614685 (pretax: -1433.944954128441)
Incremental ROIC 3y (%): -1962.3996655438532 (pretax: -2503.9538708904656)
Capital allocation category: Value Destroyer
Industry percentiles: P/E 36.19047619047619, P/B 55.23809523809524, ROIC 78.57142857142857, revenue growth 1y , 6m momentum 35.714285714285715
Sector percentiles: P/E 16.117478510028654, 6m momentum 26.826647564469912
Industry median P/E: 1.7425206697700268; industry median ROIC: 5.681103510179656
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.07080655060186508
Base cash flow: -2437908.496732026
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for FRB.AX (Basic Materials — Other Industrial Metals & Mining, Australia)
Report date: 2024-06-30 (annual)
Stock price: 0.11805555555555557
Market cap: 31001440 (USD: 20667626.666666668)
P/B ratio: 2.4529646595621033
Debt to equity: 0.0192
Current ratio: 9.28
Return on net tangible assets (%): -41.628778472622635
Buffett classification: The Gruesome
Rule of 40 score: -3555.5727272727277
Altman Z-score: 73.38860786095938 (Safe Zone)
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 1.0473803797501018
Total shareholder yield (%): 1.0473803797501018 (Low Return)
Momentum (%): 1m 0.6944444444444431, 3m -21.296296296296287, 6m -42.54629629629629, 12m 37.126068376068396, composite -9.220740413269139 (Strong Uptrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 4, short score 9, recommendation: Short
Revenue deceleration: no
Accrual ratio: -0.07606033654162847
FCF conversion rate: 0.840183902001423
Beneish M-score: -1.6697301498761745 (Possible Manipulation)
ROE (%): -49.03832543142859
Net margin (%): -4231.898181818182
Asset turnover: 0.01124611472634091
Equity multiplier (leverage): 1.0303811656875834
ROE archetype: Low Return
Treasury beta 1y: -0.008489222014592622 (R-squared: 0.0008461411468601043)
Insider 90-day net shares: 362193 (net value USD: 29774.00)
ROIC (%): -53.13540970619163 (pretax: -67.26001228631851)
Incremental ROIC 3y (%): -16.20067265157123 (pretax: -20.50718057160915)
Capital allocation category: Value Destroyer
Industry percentiles: P/E , P/B 31.723563696919232, ROIC 45.21232306411324, revenue growth 1y , 6m momentum 56.45295587010825
Sector percentiles: P/E , 6m momentum 65.88006662965019
Industry median P/E: 6.295008083084309; industry median ROIC: -14.271466134226909
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.12225
Base cash flow: -3144922.6666666665
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for FRE.AX (Healthcare — Drug Manufacturers - General, Australia)
Report date: 2025-06-30 (annual)
Stock price: 0.020833333333333332
Market cap: 7985571 (USD: 5219327.450980392)
P/B ratio: 10.994761599411966
Debt to equity: 0
Current ratio: 6.32
Return on net tangible assets (%): -174.04521541122563
Buffett classification: The Gruesome
Rule of 40 score: -20011.13452926813
Altman Z-score: -1.6150937278870945 (Distress Zone)
Piotroski F-score: 1 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0.34305624481956265
Total shareholder yield (%): 0.34305624481956265 (Low Return)
Momentum (%): 1m 0.6944444444444402, 3m -41.66666666666668, 6m -49.30555555555556, 12m -55.05952380952381, composite -48.78056011676701 (Strong Downtrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 2, short score 11, recommendation: Strong Short (Melting Ice Cube)
Revenue deceleration: no
Beneish M-score: -2.48 (Likely Safe)
Equity multiplier (leverage): 1.1743002315641762
ROE archetype: Standard Business
Treasury beta 1y: 0.0023558710960907853 (R-squared: 5.7587847500737655e-05)
Insider 90-day net shares: 355000 (net value USD: 10639.00)
ROIC (%): -434.2479817528821 (pretax: -549.6809895606102)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E , P/B 69.44444444444444, ROIC 88.88888888888889, revenue growth 1y , 6m momentum 93.05555555555556
Sector percentiles: P/E , 6m momentum 69.80659025787965
Industry median P/E: 16.627450980392158; industry median ROIC: 15.669270196462376
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.09365000000000001
Base cash flow: -1770451.6339869283
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for FRG.L (Basic Materials — Other Industrial Metals & Mining, Cyprus)
Report date: 2025-12-31 (annual)
Stock price: 0.00013333333333333334
Market cap: 6473453 (USD: 7615827.05882353)
P/B ratio: 0.014807184835516561
Debt to equity: 0.29510000000000003
Current ratio: 0.47
Interest coverage ratio: -5.405405405405405
Return on net tangible assets (%): -78.42574888463989
Buffett classification: The Gruesome
Rule of 40 score: 0
Altman Z-score: -0.6957758928917739 (Distress Zone)
Piotroski F-score: 4 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -3.3630943691617636
Total shareholder yield (%): -3.3630943691617636 (Minimal or Negative)
Momentum (%): 1m 1.3333333333333406, 3m -1.3333333333333302, 6m -1.3333333333333302, 12m -50.66666666666666, composite -17.994152046783622 (Strong Downtrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 2, short score 2, recommendation: Neutral
Revenue deceleration: no
Accrual ratio: -0.19980668955067146
FCF conversion rate: 0.4692400482509047
Beneish M-score: -2.362206587487985 (Likely Safe)
ROE (%): -56.63528722449092
Asset turnover: 0
Equity multiplier (leverage): 1.5044412367857047
ROE archetype: Low Return
Treasury beta 1y: -0.0017090004174597315 (R-squared: 8.506635425993445e-06)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): -12.887438825448614 (pretax: -16.31321370309951)
Incremental ROIC 3y (%): 10.096532970768179 (pretax: 12.78042148198504)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 1.9150707743547042, ROIC 28.80932556203164, revenue growth 1y , 6m momentum 19.816819317235637
Sector percentiles: P/E , 6m momentum 25.402554136590783
Industry median P/E: 6.295008083084309; industry median ROIC: -14.271466134226909
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.09065834417691389
Base cash flow: -2895294.117647059
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for FROG (Technology — Software - Application, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 80.16
Market cap: 9708957696 (USD: 9708957696)
P/B ratio: 6.151689340582988
Debt to equity: 0.0178
Current ratio: 2.26
Return on net tangible assets (%): -0.730013088423222
Buffett classification: The Gruesome
Analyst consensus upside (%): 92.88301725974856
Rule of 40 score: 4.447049777681212
Altman Z-score: 13.041753294389629 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -0.04110636924130646
Total shareholder yield (%): -0.04110636924130646 (Minimal or Negative)
Momentum (%): 1m 4.565614401252283, 3m 77.14917127071821, 6m 37.18979976039705, 12m 92.59971167707833, composite 66.176421386473 (Strong Uptrend)
Lynch category: Speculative (confidence: Low)
Screener: long score 6, short score 11, recommendation: Short
Revenue growth 1y (%): 25.79100868414388
Revenue deceleration: no
Accrual ratio: -0.03356166780557617
FCF conversion rate: -4.510221362041853
Beneish M-score: -2.6789118258243443 (Likely Safe)
ROE (%): -0.9127519742525995
Net margin (%): -5.368983679380687
Asset turnover: 0.11344422812326746
Equity multiplier (leverage): 1.498574342582855
ROE archetype: Low Return
FCF z-score: 4.223714883014075
Treasury beta 1y: 0.015985999290437845 (R-squared: 0.009579025850183573)
Insider 90-day net shares: -1205447 (net value USD: -98140161.00)
ROIC (%): -36.34123659131716 (pretax: -46.00156530546476)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 58.35579514824798, ROIC 64.95956873315365, revenue growth 1y 13.746630727762804, 6m momentum 6.064690026954178
Sector percentiles: P/E , 6m momentum 12.846179512846179
Industry median P/E: 2.1394954536591486; industry median ROIC: 6.21806735836372
Sector median P/E: 1.5433673469387754; sector median ROIC: 6.677876317240262
WACC: 0.1128012918417316
Base cash flow: -50776000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for FUM.L (Healthcare — Biotechnology, United Kingdom)
Report date: 2025-12-31 (annual)
Stock price: 0
Market cap: 2325311 (USD: 3142312.1621621624)
P/B ratio: 0.020723226943970822
Debt to equity: 0
Current ratio: 2.06
Return on net tangible assets (%): -319.0043558407086
Buffett classification: The Gruesome
Rule of 40 score: -449.05972790766043
Altman Z-score: -21.23170099181863 (Distress Zone)
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m -100, 3m -100, 6m -100, 12m -100, composite -97.50337381916329 (Strong Downtrend)
Lynch category: Asset Play (confidence: High)
Screener: long score 2, short score 2, recommendation: Neutral
Revenue growth 1y (%): -86.82887434831443
Net income growth 1y (%): -858.3978468844016
Revenue deceleration: yes
Revenue growth consistency score: 304.2714177228525
Accrual ratio: -0.38849715061545104
FCF conversion rate: 0.6190292081160679
Beneish M-score: -2.778529736706662 (Likely Safe)
ROE (%): -163.4976036139671
Net margin (%): -534.620843303903
Asset turnover: 0.19074372981780127
Equity multiplier (leverage): 1.6033016309453731
ROE archetype: Low Return
Treasury beta 1y: -0.003032948633185411 (R-squared: 3.631004219465676e-05)
Insider 90-day net shares: 0 (net value USD: 0.00)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E , P/B 0.45126353790613716, ROIC , revenue growth 1y 27.527075812274372, 6m momentum 79.78339350180505
Sector percentiles: P/E , 6m momentum 80.90974212034384
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.05
Base cash flow: -12092847.297297297
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for GBTG (Consumer Cyclical — Travel Services, United Kingdom)
Report date: 2026-03-31 (quarterly)
Stock price: 9.41
Market cap: 4914706432 (USD: 4914706432)
P/E ratio: 34.875
P/B ratio: 1.3310746776346154
Debt to equity: 0.988
Current ratio: 1.18
Interest coverage ratio: 1.740740740740741
Return on net tangible assets (%): -8.8
Buffett classification: The Gruesome
Analyst consensus upside (%): 70.25089605734766
Rule of 40 score: -4.9447482342219224
Altman Z-score: 0.5245544726825019 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Magic formula: return on capital % 7.496012759170655, earnings yield % 1.0032950094818323, rank 1004
Dividend yield (%): 0
Buyback yield (%): 1.0173547635408389
Debt paydown yield (%): -1.5875365229079663
Total shareholder yield (%): -0.5701817593671274 (Minimal or Negative)
Momentum (%): 1m 0.3198294243070294, 3m 64.22338568935426, 6m 29.614325068870528, 12m 40.8682634730539, composite 44.752290811623844 (Strong Uptrend)
Lynch category: Slow Grower (confidence: Medium)
Screener: long score 1, short score 6, recommendation: Neutral
Revenue growth 1y (%): 37.04551233155353
Net income growth 1y (%): -27.052631578947373
Revenue deceleration: no
Accrual ratio: 0.02093234880487603
FCF conversion rate: -0.962962962962963
Beneish M-score: -2.4548477386516403 (Likely Safe)
ROE (%): 3.204850584668687
Net margin (%): 6.42857142857143
Asset turnover: 0.16587899052920627
Equity multiplier (leverage): 3.005397558667372
ROE archetype: Low Return
P/E z-score: 1.5374187078485622
FCF z-score: 3.7907467604986755
Treasury beta 1y: 0.003999651884248446 (R-squared: 0.0006393978319465958)
Insider 90-day net shares: -2681591 (net value USD: -25069472.00)
ROIC (%): 4.847281027302981 (pretax: 6.659348701061105)
Incremental ROIC 3y (%): 44.07538475308348 (pretax: 58.09289437479408)
Capital allocation category: Turnaround Compounder
Industry percentiles: P/E 61.25000000000001, P/B 26.25, ROIC 55.00000000000001, revenue growth 1y 5, 6m momentum 3.75
Sector percentiles: P/E 59.527121001390825, 6m momentum 8.970792767732963
Industry median P/E: 7.453592814371258; industry median ROIC: 12.330112958094723
Sector median P/E: 0.5734625271900335; sector median ROIC: 5.974200780604355
WACC: 0.0767952106585425
Base cash flow: 235135135.13513508
DCF price per share: base 21.00502435806918, conservative 10.131949287474871, aggressive 41.29852644201275
Financial scorecard for GENM.TO (Basic Materials — Other Industrial Metals & Mining, Canada)
Report date: 2026-03-31 (quarterly)
Stock price: 0.41843971631205673
Market cap: 190406304 (USD: 136982952.5179856)
Debt to equity: -0.024554890742436115
Current ratio: 8.99
Interest coverage ratio: -115.3850520547945
Buffett classification: The Gruesome
Analyst consensus upside (%): 250.91803278688522
Rule of 40 score: 0
Altman Z-score: -4.046698104573029 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.0011725252772068673
Total shareholder yield (%): 0.0011725252772068673 (Low Return)
Momentum (%): 1m -7.158687943262415, 3m -11.805782869612653, 6m -20.89769746429613, 12m 49.75737215378872, composite 9.533729930703496 (Strong Uptrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 1, short score 9, recommendation: Short
Revenue deceleration: no
Accrual ratio: -0.4822685717030597
FCF conversion rate: 0.20913452441054323
Beneish M-score: -2.6308414697338516 (Likely Safe)
Asset turnover: 0
ROE archetype: Standard Business
Treasury beta 1y: 0.014939308588617141 (R-squared: 0.005660895286880457)
Insider 90-day net shares: 213436 (net value USD: 96248.00)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E , P/B , ROIC , revenue growth 1y , 6m momentum 34.138218151540386
Sector percentiles: P/E , 6m momentum 45.08606329816768
Industry median P/E: 6.295008083084309; industry median ROIC: -14.271466134226909
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.15
Base cash flow: -24583799.999999996
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for GENX.V (Healthcare — Drug Manufacturers - Specialty & Generic, Canada)
Report date: 2026-04-30 (quarterly)
Stock price: 0.014184397163120569
Market cap: 918361 (USD: 670336.4963503649)
Debt to equity: -0.7444983790572779
Current ratio: 0.02
Interest coverage ratio: -0.5322309079975948
Buffett classification: The Gruesome
Rule of 40 score: 0
Altman Z-score: -589.6857948495096 (Distress Zone)
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -6.429731679388402
Total shareholder yield (%): -6.429731679388402 (Minimal or Negative)
Momentum (%): 1m 0.7092198581560359, 3m -2.8368794326241007, 6m -34.75177304964538, 12m -35.697399527186754, composite -24.579629074684505 (Strong Downtrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 1, short score 11, recommendation: Strong Short (Melting Ice Cube)
Revenue deceleration: no
Accrual ratio: -1.797565745146671
FCF conversion rate: 0.2077966793338264
Beneish M-score: -3.931983964296351 (Likely Safe)
Asset turnover: 0
ROE archetype: Standard Business
Treasury beta 1y: 0.001518144714564141 (R-squared: 3.6688430327452585e-05)
Insider 90-day net shares: 2000000 (net value USD: 72000.00)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E , P/B , ROIC , revenue growth 1y , 6m momentum 75.366568914956
Sector percentiles: P/E , 6m momentum 61.24641833810889
Industry median P/E: 0.8814835040505258; industry median ROIC: 5.747543732928968
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.0866444161164576
Base cash flow: -238516.4285714286
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for GITS (Communication Services — Internet Content & Information, South Korea)
Report date: 2026-03-31 (quarterly)
Stock price: 2.02
Market cap: 7421900 (USD: 7421900)
P/B ratio: 4208.959653027175
Debt to equity: 0.0572
Current ratio: 0.03
Interest coverage ratio: -773.1308411214955
Return on net tangible assets (%): -224.93239007790814
Buffett classification: The Gruesome
Rule of 40 score: -53852.63574974628
Altman Z-score: 5781.09357470557 (Safe Zone)
Piotroski F-score: 4 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -0.000355237944846593
Total shareholder yield (%): -0.000355237944846593 (Minimal or Negative)
Momentum (%): 1m -15.126050420168063, 3m 37.41496598639456, 6m -0.49261083743841316, 12m -25.73529411764706, composite 8.140785049652047 (Moderate Downtrend)
Lynch category: Speculative (confidence: Low)
Screener: long score 4, short score 12, recommendation: Short
Revenue deceleration: no
Accrual ratio: -0.10200208317741369
FCF conversion rate: 0.10410005774729221
Beneish M-score: -3.1396783747693022 (Likely Safe)
ROE (%): -15.102962243360436
Net margin (%): -517701.0416666667
Asset turnover: 2.199229204105439e-05
Equity multiplier (leverage): 1.3265163396846733
ROE archetype: Low Return
Treasury beta 1y: 0.008455096863792231 (R-squared: 0.00032693623585117014)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): -54.15044051544818 (pretax: -68.54486141195973)
Incremental ROIC 3y (%): 5904.140199061005 (pretax: 7473.595188684815)
Capital allocation category: Turnaround Compounder
Industry percentiles: P/E , P/B 69.00826446280992, ROIC 64.87603305785123, revenue growth 1y , 6m momentum 19.834710743801654
Sector percentiles: P/E , 6m momentum 27.257933279088693
Industry median P/E: 1.5943877551020407; industry median ROIC: 5.940137180901089
Sector median P/E: 1.436628982900151; sector median ROIC: 4.830798676039866
WACC: 0.05
Base cash flow: -2510.9102795028894
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for GMTL (Basic Materials — Other Precious Metals & Mining, United Kingdom)
Report date: 2025-12-31 (quarterly)
Stock price: 10.93
Market cap: 425850272 (USD: 425850272)
Debt to equity: 0
Current ratio: 3.73
Buffett classification: The Gruesome
Rule of 40 score: 0
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m -25.64625850340136, 3m -40.69451980466631, 6m , 12m , composite -40.69451980466631 ()
Lynch category: Cyclical (confidence: High)
Screener: long score 2, short score 2, recommendation: Neutral
Revenue deceleration: no
Beneish M-score: -2.435680102510119 (Likely Safe)
Equity multiplier (leverage): 1.088326642038166
ROE archetype: Standard Business
Treasury beta 1y: -0.00837054400362872 (R-squared: 0.004499900667217664)
Insider 90-day net shares: 1600 (net value USD: 15880.00)
ROIC (%): -13.164244096902792 (pretax: -16.66360012266176)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B , ROIC 26.93409742120344, revenue growth 1y , 6m momentum 
Industry median P/E: 8.740359897172237; industry median ROIC: -12.638421644657798
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.10025
Base cash flow: -14724657.534246575
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for GRN.TO (Industrials — Specialty Industrial Machinery, Canada)
Report date: 2026-03-31 (quarterly)
Stock price: 0.15602836879432624
Market cap: 35116964 (USD: 25264002.877697844)
P/B ratio: 1.6858698255039721
Debt to equity: 0.11689999999999999
Current ratio: 1.54
Interest coverage ratio: -31.829268292682926
Return on net tangible assets (%): -14.836590005187619
Buffett classification: The Gruesome
Rule of 40 score: -50.817011959265486
Altman Z-score: -0.23765221097809744 (Distress Zone)
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.44387639093390496
Total shareholder yield (%): 0.44387639093390496 (Low Return)
Momentum (%): 1m 0.7092198581560202, 3m -7.0613629355534915, 6m -6.382978723404263, 12m 112.19858156028369, composite 32.419961231051644 (Strong Uptrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 2, short score 11, recommendation: Strong Short (Melting Ice Cube)
Revenue growth 1y (%): 40.12626633387168
Revenue deceleration: no
Accrual ratio: 0.03181565561851245
FCF conversion rate: 1.7296351824087957
Beneish M-score: -2.1588568786171614 (Likely Safe)
ROE (%): -8.73863887213138
Net margin (%): -20.966051969823972
Asset turnover: 0.20797850494731698
Equity multiplier (leverage): 2.0040505982099526
ROE archetype: Low Return
FCF z-score: 2.9686456294604224
Treasury beta 1y: 0.010029472668710742 (R-squared: 0.00134322649603011)
Insider 90-day net shares: 400000 (net value USD: 66800.00)
ROIC (%): 2.8970826580226916 (pretax: 4.4570502431118335)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E , P/B 42.00385356454721, ROIC 67.63005780346822, revenue growth 1y 4.431599229287091, 6m momentum 54.72061657032755
Sector percentiles: P/E , 6m momentum 51.04966717869943
Industry median P/E: 0.34832165205981025; industry median ROIC: 8.620128805291433
Sector median P/E: 0.48479532163742683; sector median ROIC: 7.0952301251284755
WACC: 0.15
Base cash flow: -351094.8905109489
DCF price per share: base 0.051264712544955106, conservative 0.05250955748609035, aggressive 0.04987777638706341
Financial scorecard for GROC.L (Basic Materials — Other Industrial Metals & Mining, United Kingdom)
Report date: 2025-11-30 (annual)
Stock price: 0.00039999999999999996
Market cap: 8369023 (USD: 11011872.368421052)
P/B ratio: 0.009058936891963808
Debt to equity: 0.0014000000000000002
Current ratio: 1.03
Return on net tangible assets (%): -11.85737094199042
Buffett classification: The Gruesome
Rule of 40 score: 0
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -0.15533473859493518
Total shareholder yield (%): -0.15533473859493518 (Minimal or Negative)
Momentum (%): 1m 1.3333333333333408, 3m -40.80000000000001, 6m -1.3333333333333368, 12m 47.999999999999986, composite 1.306432748537998 (Strong Uptrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 4, short score 9, recommendation: Short
Revenue deceleration: no
Accrual ratio: 0.029989081553839586
FCF conversion rate: 1.365942028985507
Beneish M-score: -2.4577000958211555 (Likely Safe)
ROE (%): -9.215105774655923
Asset turnover: 0
Equity multiplier (leverage): 1.1244740851564694
ROE archetype: Low Return
Treasury beta 1y: -0.001321922170237147 (R-squared: 1.916928291738414e-05)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): -7.057241977450129 (pretax: -8.933217692974846)
Incremental ROIC 3y (%): 6.948492023444475 (pretax: 8.79555952334744)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 1.1656952539550374, ROIC 19.317235636969194, revenue growth 1y , 6m momentum 21.149042464612823
Sector percentiles: P/E , 6m momentum 26.096612992781786
Industry median P/E: 6.295008083084309; industry median ROIC: -14.271466134226909
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.06173184862763061
Base cash flow: -1465789.4736842106
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for HALO (Healthcare — Biotechnology, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 81.93
Market cap: 9717962752 (USD: 9717962752)
P/E ratio: 22.677192982456138
P/B ratio: 34.903013121710465
Debt to equity: 9.9121
Current ratio: 2.76
Interest coverage ratio: 33.49981844589688
Return on net tangible assets (%): -13.695059187215989
Buffett classification: The Great
Analyst consensus upside (%): 34.4422095002321
Rule of 40 score: 25.779040024709893
Altman Z-score: 3.1402510922322278 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Magic formula: return on capital % 25.554389133252826, earnings yield % 1.5939070091308551, rank 264
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -0.020673057216509076
Total shareholder yield (%): -0.020673057216509076 (Minimal or Negative)
Momentum (%): 1m 15.151089248067464, 3m 25.35189718482253, 6m 18.36174516035829, 12m 39.407861153649826, composite 21.592937216415837 (Moderate Uptrend)
Lynch category: Fast Grower (confidence: High)
Screener: long score 7, short score 4, recommendation: Neutral
Revenue growth 1y (%): 42.22856517192037
Net income growth 1y (%): 27.0578771328168
Revenue deceleration: no
Accrual ratio: -0.010114577758317459
FCF conversion rate: 1.1751961026064819
Beneish M-score: -2.3552176866703936 (Likely Safe)
ROE (%): 111.78915999254981
Net margin (%): 39.831646792741324
Asset turnover: 0.14494226864654036
Equity multiplier (leverage): 19.363166325200222
ROE archetype: Leverage-Driven Returns
P/E z-score: 5.011963224572052
FCF z-score: 5.011963224572053
Treasury beta 1y: 0.0007291299660451268 (R-squared: 0.00010643915741798055)
Insider 90-day net shares: -114102 (net value USD: -7840471.00)
ROIC (%): 26.59130529694595 (pretax: 39.17717453275955)
Incremental ROIC 3y (%): 44.52802631174357 (pretax: 72.74608440287143)
Capital allocation category: High-Efficiency Compounder
Industry percentiles: P/E 10.740072202166065, P/B 64.8014440433213, ROIC 3.429602888086643, revenue growth 1y 9.747292418772563, 6m momentum 16.425992779783392
Sector percentiles: P/E 25.214899713467048, 6m momentum 15.257879656160458
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.07461400915933912
Base cash flow: 397970000
DCF price per share: base 169.3343065444227, conservative 83.50688646828739, aggressive 330.6525867895293
Financial scorecard for HAMA.L (Basic Materials — Gold, Liberia)
Report date: 2025-12-31 (annual)
Stock price: 0.00013333333333333334
Market cap: 2938908 (USD: 3971497.2972972975)
P/B ratio: 0.013396736266666669
Debt to equity: 1.0219
Current ratio: 0.9
Interest coverage ratio: -8
Return on net tangible assets (%): -262.93622141997594
Buffett classification: The Gruesome
Rule of 40 score: 0
Piotroski F-score: 4 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -103.73343217910534
Total shareholder yield (%): -103.73343217910534 (Minimal or Negative)
Momentum (%): 1m 1.3333333333333406, 3m -1.3333333333333302, 6m -1.3333333333333302, 12m -67.11111111111111, composite -23.403508771929822 (Strong Downtrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 0, short score 2, recommendation: Neutral
Revenue deceleration: no
Beneish M-score: -2.548535622865418 (Likely Safe)
Equity multiplier (leverage): 2.225341452292841
ROE archetype: Standard Business
Treasury beta 1y: -0.001924393527552434 (R-squared: 1.0554276945316575e-05)
Insider 90-day net shares: 750000 (net value USD: 9750.00)
ROIC (%): -44.41923551171395 (pretax: -56.22688039457462)
Incremental ROIC 3y (%): 33.84596081979044 (pretax: 42.84298837948157)
Capital allocation category: Turnaround Compounder
Industry percentiles: P/E , P/B 1.13314447592068, ROIC 46.317280453257794, revenue growth 1y , 6m momentum 13.172804532577903
Sector percentiles: P/E , 6m momentum 25.402554136590783
Industry median P/E: 8.322060300477567; industry median ROIC: -7.9824265928961236
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.05
Base cash flow: -2952702.702702703
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for HAPB.V (Technology — Consumer Electronics, Canada)
Report date: 2026-03-31 (quarterly)
Stock price: 0.02127659574468085
Market cap: 7044722 (USD: 5068145.323741008)
P/E ratio: 3.5971223021582737
Debt to equity: -0.6832989819903901
Current ratio: 0.25
Buffett classification: The Gruesome
Rule of 40 score: -201.9741180520562
Altman Z-score: -18.547621863764256 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 1.2978361517333032
Total shareholder yield (%): 1.2978361517333032 (Low Return)
Momentum (%): 1m 0.7092198581560277, 3m -27.127659574468083, 6m -51.06382978723404, 12m -71.06382978723403, composite -49.81969833183498 (Strong Downtrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 3, short score 13, recommendation: Short
Revenue growth 1y (%): -51.769696459585376
Revenue deceleration: no
Revenue growth consistency score: 119.5632305868724
Accrual ratio: 0.14384712897892699
FCF conversion rate: 8.134807128355515
Beneish M-score: -5.786627963654844 (Likely Safe)
Net margin (%): -22.838036948883598
Asset turnover: 0.08827956601804571
ROE archetype: Standard Business
P/E z-score: 1.6832029109893591
Treasury beta 1y: 0.0018828487826659417 (R-squared: 3.431514496835204e-05)
Insider 90-day net shares: 1000000 (net value USD: 42700.00)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E 28.915662650602407, P/B , ROIC , revenue growth 1y 53.01204819277109, 6m momentum 72.28915662650603
Sector percentiles: P/E 30.697364030697365, 6m momentum 78.64531197864531
Industry median P/E: 1.853419273432922; industry median ROIC: 2.6276028821781066
Sector median P/E: 1.5433673469387754; sector median ROIC: 6.677876317240262
WACC: 0.08572271022605502
Base cash flow: 26201.459854014625
DCF price per share: base 0, conservative 0, aggressive 9.894178736970321e-05
Financial scorecard for HASH.V (Healthcare — Drug Manufacturers - Specialty & Generic, Canada)
Report date: 2025-09-30 (quarterly)
Stock price: 0.0425531914893617
Market cap: 6930168 (USD: 4985732.37410072)
P/E ratio: 3.3573141486810556
P/B ratio: 1.0125370818630794
Debt to equity: 0.4921
Current ratio: 2.53
Interest coverage ratio: 0.03722619897270347
Buffett classification: The Good
Rule of 40 score: -34.42141520734609
Altman Z-score: 0.7696025345846366 (Distress Zone)
Piotroski F-score: 4 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 10.656474263582998
Total shareholder yield (%): 10.656474263582998 (High Return)
Momentum (%): 1m 20.851063829787226, 3m 16.59574468085107, 6m -65.45682102628285, 12m -80.70921985815602, composite -44.2995450102926 (Strong Downtrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 2, short score 6, recommendation: Neutral
Revenue growth 1y (%): 39.11833299842442
Revenue deceleration: no
Accrual ratio: -0.006339868655960462
FCF conversion rate: -0.2975568569804326
Beneish M-score: -2.8110774214012166 (Likely Safe)
ROE (%): -0.9245034517699482
Net margin (%): -3.2924488347552425
Asset turnover: 0.14840031708370288
Equity multiplier (leverage): 1.8921461283245486
ROE archetype: Low Return
Treasury beta 1y: 0.001214960987220337 (R-squared: 1.0991927587783898e-05)
Insider 90-day net shares: 164800 (net value USD: 19913.00)
ROIC (%): -13.668225163836626 (pretax: -17.301550840299527)
Incremental ROIC 3y (%): -5.348330605879315 (pretax: -6.770038741619386)
Capital allocation category: Value Destroyer
Industry percentiles: P/E 36.36363636363637, P/B 23.75366568914956, ROIC 72.72727272727273, revenue growth 1y 7.331378299120235, 6m momentum 89.73607038123167
Sector percentiles: P/E 16.6189111747851, 6m momentum 74.89255014326648
Industry median P/E: 0.8814835040505258; industry median ROIC: 5.747543732928968
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.05
Base cash flow: -3671410.4895104896
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for HMR (Industrials — Marine Shipping, Greece)
Report date: 2026-03-31 (quarterly)
Stock price: 1.16
Market cap: 67840792 (USD: 67840792)
P/E ratio: 3.8703905468472253
P/B ratio: 3.0399767617667925
Debt to equity: 0
Current ratio: 1.13
Return on net tangible assets (%): 19.63611116869798
Buffett classification: The Great
Analyst consensus upside (%): 213.0952380952381
Rule of 40 score: 0
Altman Z-score: 1.000008810862466 (Distress Zone)
Piotroski F-score: 2 (Weak)
Magic formula: return on capital % 65.77568678878771, earnings yield % 8.027596410487632, rank 5
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m -7.200000000000006, 3m 41.46341463414634, 6m 9.43396226415093, 12m -25.161290322580655, composite 10.514179396206616 (Strong Downtrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 7, short score 4, recommendation: Neutral
Revenue deceleration: no
Beneish M-score: -2.48 (Likely Safe)
ROE (%): 19.636111168697965
Net margin (%): 15.175208980712968
Asset turnover: 0.24101287131171925
Equity multiplier (leverage): 5.368841278417177
ROE archetype: Leverage-Driven Returns
FCF z-score: 2.5028039737013903
Treasury beta 1y: -0.004039184470083254 (R-squared: 0.00042755600332010574)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): -11.835281729257293 (pretax: -14.981369277540876)
Incremental ROIC 3y (%): -100.5783495686303 (pretax: -127.31436654257)
Capital allocation category: Value Destroyer
Industry percentiles: P/E 50.35460992907801, P/B 63.829787234042556, ROIC 80.85106382978722, revenue growth 1y , 6m momentum 45.39007092198582
Sector percentiles: P/E 43.75320020481311, 6m momentum 26.318484383000513
Industry median P/E: 1.0985700514138816; industry median ROIC: 4.741763128508353
Sector median P/E: 0.48479532163742683; sector median ROIC: 7.0952301251284755
WACC: 0.07484454570122007
Base cash flow: -29424229.411764707
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for HMT.V (Real Estate — Real Estate Services, Canada)
Report date: 2026-03-31 (quarterly)
Stock price: 0.7446808510638299
Market cap: 162444688 (USD: 116866682.0143885)
P/E ratio: 9.442446043165468
P/B ratio: 0.3324343896864133
Debt to equity: 0.7726999999999999
Current ratio: 19.96
Interest coverage ratio: 4.403645833333334
Return on net tangible assets (%): 2.03482096369324
Buffett classification: The Great
Rule of 40 score: 44.4957124292725
Altman Z-score: 0.9619774173551364 (Distress Zone)
Piotroski F-score: 4 (Weak)
Dividend yield (%): 0.38474634516827044
Buyback yield (%): 0
Debt paydown yield (%): -6.664422292466714
Total shareholder yield (%): -6.279675947298443 (Minimal or Negative)
Momentum (%): 1m 5.744680851063831, 3m 2.0212765957446917, 6m 2.7659574468085055, 12m -3.546099290780136, composite -1.332938529522284 (Moderate Downtrend)
Lynch category: Asset Play (confidence: High)
Screener: long score 3, short score 5, recommendation: Neutral
Revenue growth 1y (%): 7.501414598658163
Net income growth 1y (%): -0.3359343963764805
Revenue deceleration: no
Revenue growth consistency score: 1.6606127144301013
Accrual ratio: -0.0021621323736035537
FCF conversion rate: 1.2178073642604534
Beneish M-score: -2.288447243539047 (Likely Safe)
ROE (%): 1.8141493256576398
Net margin (%): 53.8418458781362
Asset turnover: 0.01843697978178847
Equity multiplier (leverage): 1.827524937050044
ROE archetype: Low Return
P/E z-score: 4.745731626366253
FCF z-score: 4.745731626366251
Treasury beta 1y: 0.001867481942666333 (R-squared: 0.0002893574402855477)
Insider 90-day net shares: 9000 (net value USD: 3825.00)
ROIC (%): 5.489271164769686 (pretax: 6.364015253666875)
Incremental ROIC 3y (%): 4.717784869083573 (pretax: 5.103798556636944)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 49.53051643192488, P/B 20.657276995305164, ROIC 32.863849765258216, revenue growth 1y 21.830985915492956, 6m momentum 22.535211267605636
Sector percentiles: P/E 34.161490683229815, 6m momentum 26.39751552795031
Industry median P/E: 0.9094611103569973; industry median ROIC: 3.7422962097312933
Sector median P/E: 4.332660990050401; sector median ROIC: 3.0025005588392872
WACC: 0.05
Base cash flow: 14309489.05109489
DCF price per share: base 18.635592126792663, conservative 8.047074397299308, aggressive 42.001067157062536
Financial scorecard for HNGE (Healthcare — Health Information Services, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 74.31
Market cap: 5750117376 (USD: 5750117376)
P/E ratio: 14.99895031427921
P/B ratio: 6.7644514910771605
Debt to equity: 0.022400000000000003
Current ratio: 1.3
Return on net tangible assets (%): 14.772184992882693
Buffett classification: The Great
Analyst consensus upside (%): 135.65871369294607
Rule of 40 score: 23.16289757916853
Altman Z-score: 6.919988819802014 (Safe Zone)
Piotroski F-score: 8 (Strong)
Magic formula: return on capital % 22.444080512863582, earnings yield % 0.568489057123312, rank 871
Dividend yield (%): 0
Buyback yield (%): 1.8254583886949858
Debt paydown yield (%): 0.018608315796578272
Total shareholder yield (%): 1.844066704491564 (Low Return)
Momentum (%): 1m 5.314625850340136, 3m 67.78053736735156, 6m 74.60056390977444, 12m 61.61374510656808, composite 65.27970883516205 (Strong Uptrend)
Lynch category: Slow Grower (confidence: Medium)
Screener: long score 12, short score 1, recommendation: Long
Revenue growth 1y (%): 47.229557843731065
Net income growth 1y (%): -71.04349904791736
Revenue deceleration: no
Accrual ratio: -0.008720543564713898
FCF conversion rate: 1.1829025278979732
Beneish M-score: -2.004652214225817 (Likely Safe)
ROE (%): 10.18061255245647
Net margin (%): 19.268596378636037
Asset turnover: 0.24744220010152476
Equity multiplier (leverage): 2.1352565440170643
ROE archetype: Standard Business
FCF z-score: 2.4320931249311464
Treasury beta 1y: 0.003241496685147178 (R-squared: 0.0005379767632405221)
Insider 90-day net shares: -3686059 (net value USD: -275343004.00)
ROIC (%): -1900.379034033373 (pretax: -2405.543081054903)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 21.578947368421055, P/B 50.526315789473685, ROIC 63.68421052631579, revenue growth 1y 5.7894736842105265, 6m momentum 2.631578947368421
Sector percentiles: P/E 21.41833810888252, 6m momentum 3.510028653295129
Industry median P/E: 8.33027298322928; industry median ROIC: 0.6291287571896624
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.10174517674572925
Base cash flow: -419662000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for HYSG.BR (Technology — Software - Application, United Kingdom)
Report date: 2025-12-31 (annual)
Stock price: 4.551724137931035
Market cap: 129361160 (USD: 174812378.3783784)
P/E ratio: 36.92307692307692
P/B ratio: 1.0309008211096797
Debt to equity: 0.0407
Current ratio: 2.03
Interest coverage ratio: 20.648535564853557
Return on net tangible assets (%): 59.387170944582614
Buffett classification: The Great
Analyst consensus upside (%): 14.583333333333337
Rule of 40 score: 31.338463505305526
Piotroski F-score: 8 (Strong)
Magic formula: return on capital % 27.732509131778592, earnings yield % 5.572323910851792, rank 1196
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 1.145534496079632
Total shareholder yield (%): 1.145534496079632 (Low Return)
Momentum (%): 1m -1.4925373134328292, 3m -2.13793103448276, 6m -0.1407459535538329, 12m 13.127646702964316, composite 4.187674989334311 (Moderate Uptrend)
Lynch category:  (confidence: Low)
Screener: long score 14, short score 1, recommendation: Strong Long (L/S Compounder)
Revenue deceleration: no
Accrual ratio: -0.04054273948130528
FCF conversion rate: 2.2076941232003775
Beneish M-score: -2.611851421583664 (Likely Safe)
ROE (%): 3.9503069657491277
Net margin (%): 7.7926138453615845
Asset turnover: 0.4307973091806783
Equity multiplier (leverage): 1.1767242589940399
ROE archetype: Low Return
P/E z-score: 4.930649752919373
FCF z-score: 4.930649752919369
Treasury beta 1y: 0.019992681455849787 (R-squared: 0.0003837506816012254)
Insider 90-day net shares: 45501 (net value USD: 265195.00)
ROIC (%): 4.676333109509095 (pretax: 4.806568489948574)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E 47.97843665768194, P/B 14.555256064690028, ROIC 42.04851752021563, revenue growth 1y , 6m momentum 23.045822102425877
Sector percentiles: P/E 45.94594594594595, 6m momentum 31.664998331665
Industry median P/E: 2.1394954536591486; industry median ROIC: 6.21806735836372
Sector median P/E: 1.5433673469387754; sector median ROIC: 6.677876317240262
WACC: 0.0607255617684593
Base cash flow: 17102702.702702705
DCF price per share: base 26.896384876118614, conservative 16.735914314522017, aggressive 44.31296467199641
Financial scorecard for HZO (Consumer Cyclical — Specialty Retail, United States)
Report date: 2026-06-30 (quarterly)
Stock price: 36.33
Market cap: 800282880 (USD: 800282880)
P/E ratio: 228.87499999999997
P/B ratio: 0.8368755104014075
Debt to equity: 1.1514
Current ratio: 1.23
Interest coverage ratio: 2.600908455625437
Return on net tangible assets (%): 5.158085534226656
Buffett classification: The Great
Analyst consensus upside (%): 3.3861277990169367
Rule of 40 score: 27.797677171445983
Altman Z-score: 1.2062994541033043 (Distress Zone)
Piotroski F-score: 9 (Strong)
Magic formula: return on capital % 4.213520988358732, earnings yield % 2.1281856994081743, rank 927
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 11.952523587659405
Total shareholder yield (%): 11.952523587659405 (High Return)
Momentum (%): 1m -2.022653721682848, 3m 22.240915208613725, 6m 28.96698615548454, 12m 59.97357992073975, composite 38.161330397455906 (Strong Uptrend)
Lynch category: Asset Play (confidence: Medium)
Screener: long score 4, short score 3, recommendation: Neutral
Revenue growth 1y (%): -6.984763200382249
Revenue deceleration: no
Revenue growth consistency score: 6.717430183521049
Accrual ratio: -0.025640128186057286
FCF conversion rate: 4.9327027545216335
Beneish M-score: -2.586217174246842 (Likely Safe)
ROE (%): 1.640722035137058
Net margin (%): 2.5598028982851755
Asset turnover: 0.2546962456285529
Equity multiplier (leverage): 2.516552187323543
ROE archetype: Low Return
FCF z-score: 3.2946269597914584
Treasury beta 1y: 0.004699158821627145 (R-squared: 0.0014006354796773544)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): 4.022337846842988 (pretax: 5.09156689473796)
Incremental ROIC 3y (%): -10.000182814353336 (pretax: -13.619776615905701)
Capital allocation category: Value Destroyer
Industry percentiles: P/E 61.502347417840376, P/B 23.943661971830984, ROIC 53.990610328638496, revenue growth 1y 43.66197183098591, 6m momentum 9.859154929577464
Sector percentiles: P/E 63.942976356050075, 6m momentum 9.248956884561892
Industry median P/E: 2.3211958916121533; industry median ROIC: 6.169113478954271
Sector median P/E: 0.5734625271900335; sector median ROIC: 5.974200780604355
WACC: 0.07271785462085653
Base cash flow: -31482000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for IDYA (Healthcare — Biotechnology, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 35.4
Market cap: 3408128000 (USD: 3408128000)
P/B ratio: 3.4225854560546782
Debt to equity: 0.0305
Current ratio: 10.74
Return on net tangible assets (%): -10.494661606564618
Buffett classification: The Gruesome
Analyst consensus upside (%): 60.68427370948379
Rule of 40 score: -1205.1776332158329
Altman Z-score: 21.22805505244849 (Safe Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0.00026407458874784046
Debt paydown yield (%): -0.02012835198677984
Total shareholder yield (%): -0.019864277398032 (Minimal or Negative)
Momentum (%): 1m -2.4255788313120243, 3m 15.196876016921568, 6m 1.7241379310344869, 12m 42.56947241240435, composite 21.011528746512944 (Strong Uptrend)
Lynch category: Speculative (confidence: Low)
Screener: long score 4, short score 9, recommendation: Short
Revenue deceleration: no
Accrual ratio: -0.020939658041045542
FCF conversion rate: 0.7726585412882209
Beneish M-score: -1.6303552863792121 (Possible Manipulation)
ROE (%): -10.05396895522449
Net margin (%): -1502.1189024390244
Asset turnover: 0.0061317809458646
Equity multiplier (leverage): 1.0915574474250345
ROE archetype: Low Return
Treasury beta 1y: -0.008204324348167086 (R-squared: 0.005304246319411382)
Insider 90-day net shares: -9550 (net value USD: -382131.00)
ROIC (%): -30.58797209935352 (pretax: -38.71895202449813)
Incremental ROIC 3y (%): -18.06550813507436 (pretax: -22.86773181654982)
Capital allocation category: Value Destroyer
Industry percentiles: P/E , P/B 37.18411552346571, ROIC 16.967509025270758, revenue growth 1y , 6m momentum 26.624548736462096
Sector percentiles: P/E , 6m momentum 26.28939828080229
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.05
Base cash flow: -111473000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for IJ8.DE (Industrials — Specialty Industrial Machinery, United Kingdom)
Report date: 2025-10-31 (quarterly)
Stock price: 1.375
Market cap: 833073472 (USD: 1096149305.2631578)
P/B ratio: 2.6357807564735296
Debt to equity: 0.0699
Current ratio: 2.62
Buffett classification: The Gruesome
Rule of 40 score: 0
Piotroski F-score: 1 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -0.2678739320925906
Total shareholder yield (%): -0.2678739320925906 (Minimal or Negative)
Momentum (%): 1m -15.384615384615385, 3m -34.305555555555564, 6m 42.53048780487805, 12m 55.833333333333336, composite 30.797199638663056 (Strong Uptrend)
Lynch category:  (confidence: Low)
Screener: long score 2, short score 2, recommendation: Neutral
Revenue deceleration: no
Beneish M-score: -2.4699734091610335 (Likely Safe)
Equity multiplier (leverage): 1.5684684749158004
ROE archetype: Standard Business
Treasury beta 1y: -0.0745341270565376 (R-squared: 0.000826588549872377)
Insider 90-day net shares: -700015 (net value USD: -1637318.00)
ROIC (%): -110.86204095447644 (pretax: -140.33169741072967)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E , P/B 51.05973025048169, ROIC 86.1271676300578, revenue growth 1y , 6m momentum 10.404624277456648
Sector percentiles: P/E , 6m momentum 7.808499743983615
Industry median P/E: 0.34832165205981025; industry median ROIC: 8.620128805291433
Sector median P/E: 0.48479532163742683; sector median ROIC: 7.0952301251284755
WACC: 0.15
Base cash flow: -62199999.99999999
DCF price per share: base 0, conservative 0, aggressive 0